The Journal for Nurse Practitioners
Volume 4, Issue 3 , Pages 201-207 , March 2008

Assessing Functional Impairment During and Between Migraine Attacks

  • Wendy L. Wright

      Affiliations

    • Wendy Wright, MS, APRN, BC, FAANP, is an adult/family nurse practitioner in Amherst, New Hampshire. Editorial support was provided by Ann Rorai (Phase Five Communications, New York) with funding from OrthoMcNeil Neurologics. She is also a consultant for OrthoMcNeil and serves on the speakers' bureau for GSK and Pfizer.

References 

  1. Leonardi M , Steiner TJ , Scher AT , Lipton RB . The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF) . J Headache Pain . 2005;6:429–440
  2. Lipton RB , Bigal ME , Diamond M , et al.   Migraine prevalence, disease burden, and the need for preventive therapy . Neurology . 2007;68:343–349
  3. Lipton RB , Bigal ME , Kolodner K , et al.   The family impact of migraine: population-based studies in the USA and UK . Cephalalgia . 2003;23:429–440
  4. MacGregor EA , Brandes J , Eikermann A , Giammarco R . Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey—Phase III . Curr Med Res Opin . 2004;20:1143–1150
  5. Dahlof CG , Dimenas E . Migraine patients experience poorer subjective well-being/quality of life even between attacks . Cephalalgia . 1995;15:31–36
  6. Peres M , Mercante J , Guendler V , et al.   Cephalalgiaphobia: a possible specific phobia of illness . J Headache Pain . 2007;8:56–59
  7. Edmeads J , Findlay H , Tugwell P , et al.   Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey . Can J Neurol Sci . 1993;20:131–137
  8. Harris Interactive/Ortho-McNeil Neurologics. New survey reveals worrying between attacks can extend suffering for migraineurs [press release]. June 8, 2006. Available at: www.jnj.com. Accessed June 26, 2007.
  9. Silberstein SD , Olesen J , Bousser MG , et al.   The international classification of headache disorders, 2nd edition (ICHD-II) – revision of criteria for 8.2 medication-overuse headache . Cephalalgia . 2005;25:460–465
  10. Bigal ME , Lipton RB . When migraine progresses: transformed or chronic migraine . Expert Rev Neurother . 2006;6:297–306
  11. National Headache Foundation (NHF) Press Release  . The NHF unveils migraine prevention consensus statement . Available at: www.headaches.org Accessed April 30, 2007.
  12. Hahn SR, Nelson M, Lipton RB: Provider-patient migraine discussions: results of American Migraine Communication Study (AMCS). Presented at: 58th American Academy of Neurology Annual Meeting; April 1–8, 2006; San Diego, CA. Poster P03.190.
  13. Diamond S , Bigal ME , Silberstein S , et al.   Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study . Headache . 2007;47:355–363
  14. Buse CD, Bigal ME, Rupnow MFT, et al. The Migraine Interictal Burden Scale (MIBS): Results of a population-based validation study. Presented at: 49th Annual American Headache Society Annual Scientific Meeting; June 7–10, 2007; Boston, MA. Poster F64.
  15. Terwindt GM , Ferrari MD , Tijhuis M , et al.   The impact of migraine on quality of life in the general population: the GEM study . Neurology . 2000;55:624–629
  16. Linde M , Dahlof C . Attitudes and burden of disease among self-considered migraineurs—a nation-wide population-based survey in Sweden . Cephalalgia . 2004;24:455–465
  17. Clarke CE , MacMillan L , Sondhi S , Wells NE . Economic and social impact of migraine . QJM . 1996;89:77–84
  18. Hahn SR, Cady RK, Nelson MR, et al. Improving healthcare professional-patient communication to promote more effective assessment of migraine impairment during and between attacks: results of the American Migraine Communication Study (AMCS) Phase II. Presented at: Diamond Headache Clinic's 20th Annual Practicing Physicians Approach to the Difficult to Treat Headache Patient; February 13–17, 2007; Rancho Mirage, CA.
  19. Migraine Disability Assessment (MIDAS) Test  . Available at: http://www.migraine-disability.net Accessed April 30, 2007.
  20. Headache Impact Test (HIT)  . Available at: http://www.headachetest.com/ Accessed April 30, 2007.
  21. Martin BC , Pathak DS , Sharfman MI , et al.   Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1) . Headache . 2000;40:204–215
  22. Nachit-Ouinekh F , Dartigues JF , Henry P , et al.   Use of the headache impact test (HIT-6) in general practice: relationship with quality of life and severity . Eur J Neurol . 2005;12:189–193
  23. Stewart W , Lipton R . Need for care and perceptions of MIDAS among headache sufferers study . CNS Drugs . 2002;16(suppl 1):5–11
  24. Dowson AJ . Assessing the impact of migraine . Curr Med Res Opin . 2001;17:298–309
  25. Baos V , Ester F , Castellanos A , et al.   Use of a structured migraine diary improves patient and physician communication about migraine disability and treatment outcomes . Int J Clin Pract . 2005;59:281–286
  26. Ramadan M , Silberstein SD , Freitag FG , et al.   Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management for prevention of migraine. Neurology [serial online] . Available at: www.aan.com 2000; Accessed April 14, 2007.
  27. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review). 2000. Report of the quality standards subcommittee of the American Academy of Neurology (AAN). St Paul, MN: AAN Enterprises; 2000.
  28. Linde K , Rossnagel K . Propranolol for migraine prophylaxis . Cochrane database of systematic reviews . 2004;2:CD003225
  29. Depakote ER (divalproex sodium extended-release) full prescribing information . North Chicago, IL: Abbot Laboratories; 2006;
  30. Freitag FG , Diamond S , Diamond ML , Urban GJ . Divalproex in the long-term treatment of chronic daily headache . Headache . 2001;41:271–278
  31. Brandes JL , Saper JR , Diamond M , et al.   Topiramate for migraine prevention: a randomized controlled trial . JAMA . 2004;291:965–973
  32. Silberstein SD , Neto W , Schmitt J , Jacobs D  MIGR-001 Study Group . Topiramate in migraine prevention: results of a large controlled trial . Arch Neurol . 2004;61:490–495
  33. Diener HC , Tfelt-Hansen P , Dahlof C , et al.   Topiramate in migraine prophylaxis—results from a placebo-controlled trial with propranolol as an active control . J Neurol . 2004;251:943–950
  34. Silberstein SD , Lipton RB , Dodick DW , et al.   Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial . Headache . 2007;47:170–180
  35. Diamond M , Dahlof C , Papadopoulos G , Neto W , Wu SC . Topiramate improves health-related quality of life when used to prevent migraine . Headache . 2005;45:1023–1030
  36. Silberstein SD , Loder E , Forde G , et al.   The impact of migraine on daily activities: effect of topiramate compared with placebo . Curr Med Res Opin . 2006;22:1021–1029
  37. Brandes JL , Kudrow DB , Rothrock JF , et al.   Assessing the ability of topiramate to improve the daily activities of patients with migraine . Mayo Clinic Proc . 2006;81:1311–1319

PII: S1555-4155(08)00006-8

doi: 10.1016/j.nurpra.2008.01.004

The Journal for Nurse Practitioners
Volume 4, Issue 3 , Pages 201-207 , March 2008

Article Tools

* Image Usage & Resolution